NEW YORK (GenomeWeb News) – RayBiotech today announced a deal with Norwegian organizations for the use of RayBiotech's antibody arrays for sample analysis services.

The deal, which involves Oslo University Hospital and the University of Oslo, provides for the use of RayBiotech's array technology for the high-throughput detection and analysis of protein biomarkers in biological samples. Potential biomarkers include cytokines, growth factors, and other secreted factors related to complex diseases, such as cancer.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

23andMe's Anne Wojcicki ponders DNA and what it means to be human in a New York Times essay.

A new estimate places the last universal common ancestor to life on Earth as living 3.9 billion years ago, Inverse reports.

In PNAS this week: retinitis pigmentosa gene therapy, role of microbiome in growth stunting, and more.

Bloomberg reports that researchers and drug companies are modeling anti-obesity treatments after the rare genetic condition essential fructosuria.